DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2005
DUOPHARMA BIOTECH BHD |
Quarterly report for the financial period ended | 31/12/2005 |
Quarter | 4 |
Financial Year End | 31/12/2005 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2005 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2005 | 31/12/2004 | 31/12/2005 | 31/12/2004 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 22,895 | 21,104 | 94,298 | 79,140 |
2 | Profit/(loss) before tax | 8,417 | 6,373 | 33,458 | 26,614 |
3 | Profit/(loss) after tax and minority interest | 5,981 | 5,853 | 23,512 | 22,755 |
4 | Net profit/(loss) for the period | 5,981 | 5,853 | 23,512 | 22,755 |
5 | Basic earnings/(loss) per share (sen) | 4.29 | 4.43 | 17.54 | 17.24 |
6 | Dividend per share (sen) | 17.50 | 6.00 | 17.50 | 9.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share (RM) | 1.0100 | 0.8100 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
Company Name | DUOPHARMA BIOTECH BHD |
Stock Name | DBIOTEC |
Date Announced | 27 Feb 2006 |
Category | Financial Results |
Reference No | CS-060221-40379 |